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Abstract
Background: There is experimental evidence from animal models favoring the notion that the
disruption of interactions between stroma and epithelium plays an important role in the initiation
of carcinogenesis. These disrupted interactions are hypothesized to be mediated by molecules,
termed morphostats, which diffuse through the tissue to determine cell phenotype and maintain
tissue architecture.
Methods: We developed a computer simulation based on simple properties of cell renewal and
morphostats.
Results: Under the computer simulation, the disruption of the morphostat gradient in the stroma
generated epithelial precursors of cancer without any mutation in the epithelium.
Conclusion: The model is consistent with the possibility that the accumulation of genetic and
epigenetic changes found in tumors could arise after the formation of a founder population of
aberrant cells, defined as cells that are created by low or insufficient morphostat levels and that no
longer respond to morphostat concentrations. Because the model is biologically plausible, we hope
that these results will stimulate further experiments.
Background
Cell-to-cell and/or tissue-to-tissue communication is cru-
cial for tissue organization. Its disruption can play an
important role in the initiation of cancer [1,2]. These
communications involve substances analogous to a mor-
phogen in the developing embryo that diffuse through the
tissue creating a concentration gradient. Local concentra-
tions of these substances influence the phenotype of
neighboring cells. These substances have been called mor-
phostats [3,4]. Various models have been proposed to
explain how the concentration gradient of morphogens
generates differentiated tissues during embryogenesis [3];
these models could be applied to examine the role of mor-
phostats in carcinogenesis but, for our purpose here, we
assume a simple model in which the source of the mor-
phostat gradient lies in the stroma.
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One suggestive piece of evidence for the existence of mor-
phostats is the development of tumors when foreign bod-
ies, which serve as barriers to potential diffusion, have
been inserted subcutaneously in mice. Early experiments
found a carcinogenic response for various chemically inert
substances inserted subcutaneously, but only when they
were implanted intact and not in powdered form [5]. If
there were chemically induced genetic changes, the rate of
tumor formation from a foreign-body implant in pow-
dered form would be the same or greater than the rate of
tumor formation from a solid implant of the same mass
(and less surface area). Because this was not the case, it is
highly doubtful that there was a chemically-induced
genetic initiation (like a mutation). Without genetic initi-
ation, it is unlikely that an intact implant would have the
role of a promoter. Later experiments involving the subcu-
taneous insertion of a Millipore filter showed that tumors
formed only when the pores in the filter were sufficiently
small [6], suggesting a threshold size of pore that permits
morphostat diffusion. An alternative explanation for the
initiation of tumors in foreign-body experiments is that
inflammatory responses lead to mutations that cause can-
cer. However, this explanation does not fit the fact that
inflammation (specifically, filter invasion by cytoplasmic
process and phagocytic and lysosomal activity) was asso-
ciated with large pore implants when almost no tumors
were observed, but was not associated with small pore
implants when many tumors were observed [6]. Thus,
because an explanation for this peculiar phenomenon
based on an initiating event involving genetic mutations
appears unlikely, we have recently identified "foreign-
body" carcinogenesis as a key paradox in the initial steps
of carcinogenesis if one were to adopt the explanation
suggested by the somatic mutation theory [7].
Other evidence consistent with the role of morphostats in
carcinogenesis stems from transplantation experiments in
which tumors arise when normal epithelial cells were
transplanted next to stromal cells in rats treated with
either a physical carcinogen [8] or a chemical carcinogen
with a very short half-life to reduce the chance of indirect
exposure of the epithelial cells to the carcinogen [9].
Even though some putative morphostats have been iden-
tified [3], the full spectrum is, as yet, unknown, as are the
mechanisms by which they influence carcinogenesis.
Based on the prevalent somatic mutation theory, one
hypothesis would be that at least two mutations in genes
regulating cell proliferation are required: one in an epithe-
lial cell and one in a surrounding stromal cell [10]. Recent
data showing lack of evidence for mutations in the stroma
of tumors argues against this option [11]. An alternative
hypothesis is that the perturbation in a morphostat gradi-
ent could initiate carcinogenesis without any requirement
for a mutation. To investigate this latter hypothesis, we
developed a simple mathematical model (computer sim-
ulation) of the process of cell renewal, the diffusion of a
morphostat, and the effect of morphostat concentrations
on cell phenotype. We then mathematically perturbed the
model to simulate disruption of the morphostat gradient
arising from a block in the stroma.
Our goal was to determine whether or not disruption of a
morphostat gradient is sufficient to create aberrant cells in
the context of cell renewal without the need to postulate a
mutation in the epithelial cells to initiate the develop-
ment of cancer. We define an aberrant cell as an epithelial
cell created by a low morphostat level, the phenotype of
which is no longer under the control of that morphostat
gradient. Because these aberrant cells are unable to
respond to a morphostat, we view them as precursors of
cancer that have the potential to obtain a selective advan-
tage as a result of higher proliferation rates or a propensity
toward genetic or epigenetic aberration, or some combi-
nation of these.
If our mathematical model provides evidence that aber-
rant cells in a dynamic setting of cell renewal can indeed
be generated without mutations, it would provide impe-
tus for new research directions in carcinogenesis and, spe-
cifically, attempts at empiric experimental testing under a
paradigm that is quite different from the dominant
somatic mutation theory.
Most mathematical models of carcinogenesis [12-14]
begin with a nascent tumor cell. In contrast our model
begins with normal tissue. Our model is related to math-
ematical models for morphogenesis in that it depends on
diffusion. The classic mathematical model for morpho-
genesis was a set of differential equations proposed by AM
Turing [15] in a 1952 paper in which he coined the word
"morphogen." Turing, who was a computer pioneer and a
cryptologist, noted, then, the future possibility of mode-
ling morphogen diffusion using a digital computer. A cell
polarity model of carcinogenesis [14] also involves mor-
phogens, but the morphogens in that model play a very
different role from those in our model, in that they induce
a loss of cell polarity leading to division in an abnormal
direction rather than influencing tissue phenotype.
Methods
Our model focuses on the effect of morphogens on tissue
architecture. The two-dimensional mathematical model
of the tissue consists of two arrays of numbers, each corre-
sponding to a grid of rectangles, one for cell type and one
for morphostat levels.
Cell type
The first array of numbers codes for cell type, displayed as
different colored rectangles. Some rectangles representBMC Cancer 2009, 9:89 http://www.biomedcentral.com/1471-2407/9/89
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biological cells, sometimes called in silico cells [12,13].
Other rectangles represent the lumen as would be found
in hollow organs or the free surface as in the skin. Lastly,
some rectangles represent what we call open spaces,
which are mathematical indications of room for cells to
move during the tissue-renewal process. The word "cell"
has a mathematical meaning as a quantity governed by
rules involving geometrically adjacent quantities The
mathematical term "cellular automata" refers to an array
of numbers whose "life processes" are governed by simple
mathematical rules related to nearby cells [16].
The initial grid of cell types displays a structured epithelial
tissue above a layer of stromal cells (Figure 1, Panel A,
left). The epithelial tissue consists of (a) a stem cell cen-
tered just below the bottom layer, (b) middle-layer cells
on either side of the stem cell and in layers above the stem
cell, and (c) a top-layer of cells below the lumen space.
The term "stem cells" here refers to the normal stem cells
that generate tissue renewal, and not to cancer stem cells.
Regarding the controversy about whether stem cells are
defined by their "niche" (i.e., their microenvironment) or
its alternative, namely, that "stemness" is an intrinsic cel-
lular property, we subscribe to the former. However, in
the context of this simulation, these hypotheses are equiv-
alent. A block can be mathematically introduced in the
stroma layer (Figure 2, Panel A, left).
Morphostat level
The second array of numbers codes for morphostat level
displayed as shaded rectangles on a gray scale. The initial
morphostat gradient ranges from the highest concentra-
No block in the stroma: snapshots Figure 1
No block in the stroma: snapshots. Panel A shows stable tissue architecture and a stable morphostat gradient. In Panel B 
some top-layer cells have sloughed off and were replaced by middle layer cells, and some middle layers cells have moved 
upward leaving open spaces. In Panel C, the middle layer cells on top have become top layer cells because they experienced the 
threshold Level 0 morphostat concentration; also open spaces on top have been classified as lumen.
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tion at the bottom layer of the epithelium (just above the
stromal cells) and falls to the threshold level at the top
layer (Figure 1, Panel A, right). The threshold level defines
the morphostat concentration in middle-layer cells at
which differentiation occurs. The initial threshold level of
the morphostat concentration is based on the initial tissue
architecture. The highest morphostat concentration is at
the bottom layer and set to level 6. Therefore, the initial
morphostat concentration at the top layer, which is six
cells away, is set to 0. Level 0 is thus set as the threshold
level for a middle-layer cell to become a top-layer cell.
Cell renewal model
We model biological cell renewal using various rules for
the movement and differentiation (change of phenotype)
of cells based on the type of cell, the type of adjacent cells,
and the strength of the morphostat gradient at an adjacent
cell. (An adjacent cell is defined as a cell above, below, or
lateral to any particular cell). There is only one parameter
specifying a probability distribution function, namely the
probability of sloughing of a top layer cell. The remaining
changes are simple functions of cell type and morphostat
level.
The first three rules are motivated by findings summarized
in LeBlond [17] that "the cells of the intestinal epithelium
migrate from the crypts along the villus surface to the vil-
lus tips where they fall to their death in the lumen, that
the alveolar cells of the lung migrate out the alveolar tis-
sues to the alveolar spaces and from the bronchia and tra-
Solid block in the stroma: snapshots Figure 2
Solid block in the stroma: snapshots. Panel A shows stable tissue architecture and a stable morphostat gradient when a 
block has been inserted in the stroma. In Panel B some top-layer cells have sloughed off and were replaced by middle layer 
cells, some middle layers cells have moved upward leaving open spaces, and one top layer cell has become aberrant due to 
experiencing a morphostat level below the Level 0 threshold. In Panel C, middle layer cells on top have become top layer cells 
due to reaching the threshold morphostat Level 0.
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chea, to fall into the esophagus, and finally that
lymphocytes leave the thymus in large numbers to enter
the blood circulation." This cell renewal process has been
postulated to arise from cell pressure arising from cell
division in the basal layer [17]. Using the following three
rules, we model this pressure as open space moving from
the top layer to the stem cell, which translates into cell
movement from the stem cell to the top layer.
Rule 1. Sloughing off
If a top-layer cell is below a lumen space, it sloughs off
with a given probability and creates an open space in its
former position.
Rule 2. Upward cell movement
If a middle-layer cell is below an open space, it moves
upward into the open space, creating an open space in its
former position.
Rule 3. Lateral cell movement
If a middle-layer cell is lateral to an open space, if upward
cell movement into the open space is not possible, and if
there is no stem cell below the open space, a middle-layer
cell adjacent to the open space moves laterally into the
open space (and toward an imaginary vertical line at the
horizontal position of the stem cell), creating an open
space in its former position.
Rule 1 is based on the statement in LeBlond [17] that "an
important feature of renewal systems is the existence of an
outlet allowing eventual elimination of cells produced.
Thus, the differentiated cells arising in epithelia are cast
off to the outside or into a lumen, the blood cells formed
in hematopoietic organs pass into circulation, and so on."
Rules 2 and 3 mimic cell migration in the renewing tissue.
In our model, the major movement is upward with an
additional lateral movement from the stem cell when
upward movement is not possible. Cell renewal also
involves stem cell division summarized as follows.
Rule 4. Stem-cell division
If a stem cell is adjacent to an open space, the stem cell
undergoes division to generate both a middle-layer cell to
fill the open space and a new stem cell at the original fixed
location.
Rule 4 is based on three statements in LeBlond [17]: (i)
"in most renewal systems...division is chiefly seen in cells
that are little or not differentiated, the stem cells," (ii)
"mitoses of stem cells have to provide a continuous sup-
ply of differentiated cells, while maintaining their own
stock," and (iii) "when single cells are considered, the
steady state implies that, for any cell lost from the popu-
lation, another cell must divide and thus make up the
loss. The simplest way for nature to achieve this aim
would be for each division of a stem cell to produce one
daughter cell that differentiates and another one that
remains the stem cell."
Another rule is needed for changes in the morphostat con-
centration.
Rule 5. Morphostat changes
The morphostat concentration in a mathematically
defined cell (which would be on the outside of a physical
cell) equals the maximum of the morphostat concentra-
tions in the adjacent cells (excluding open space) minus
one.
Rule 5 is based on an experimentally supported theory
that morphogen diffusion occurs through the extracellular
matrix [18,19]. The effect of morphostats on cell pheno-
type is modeled by Rules 6 and 7.
Rule 6. Differentiation
A middle-layer cell becomes a top-layer cell if the mor-
phostat concentration drops to a threshold level.
Rule 6 is based on (i) a study of the rat esophagus where
numerous radioactively labeled spinous layer cells
appeared two days after basal cells were radioactively
labeled, suggesting a phenotypic change after cell move-
ment to the spinous layer [20] and (ii) the experimental
result that a cell can "read its position in concentration
gradient without reference to its neighbors" [21]. The
premise that the morphostat concentration is causing a
phenotypic change is more speculative
Rule 7. Generation of aberrant cells
If the morphostat concentration of a middle-layer (top-
layer) cell drops below the threshold level, the cells
become an aberrant middle-layer (top-layer).
Rule 7 is the key speculation. The purpose of the model is
to determine how Rule 7 fares in the context of cell
renewal.
These rules have been summarized in a precise mathemat-
ical formulation [see Additional file 1] and implemented
in software written in Mathematica, Version 7 [22] [see
Additional file 2].
Application of Rules
We successively applied Rules 1 to 4 from the top to the
bottom rows of cells. Within each row, we applied the
rules from the middle to the outside, but we also investi-
gated applying them from the outside to the middle. For
the layer above the stem cell, we repeated the rules a
number of times equal to half the width of the plot in
order to complete the cell-renewal cycle within a round.BMC Cancer 2009, 9:89 http://www.biomedcentral.com/1471-2407/9/89
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We used a sloughing probability of 0.3 but also investi-
gated other sloughing probabilities.
After the aforementioned round of cell movements, we
renamed any open space below the lumen space as a
lumen space. Then we evaluated the morphostat concen-
tration at each cell according to Rule 5. The process mim-
ics passive diffusion from higher to lower morphostat
concentrations and determines cell-fate change across the
morphostat gradient. We applied Rule 5 from top to bot-
tom and left to right in the grid (also considering right to
left), repeating this procedure once to ensure sufficient
update. Then we mathematically changed the cell pheno-
types according to Rules 6 and 7.
The disruption of the morphostat gradient was created by
assigning an unchanging negative value for the morphos-
tat concentration in some stroma cells bordering the epi-
thelial cells. When the morphostat concentrations were
updated, these negative values mathematically prevented
the morphostat concentration in the stroma from directly
influencing the morphostat concentration of the epithe-
lial cells on the other side of the block, which is the math-
ematical equivalent of preventing diffusion across the
block. We considered both a solid block (Figure 3) and a
perforated block (Figure 4). The analogy to the foreign
body experiments involving implants is clear. As a check
of stability, temporary initial perturbations in the mor-
phostat gradient were also investigated.
Results
With no disruption of the morphostat gradient, the tissue
was in equilibrium under cell renewal (Figure 1): the cell
layers and the morphostat gradient remained unchanged
from the initial conditions of the model. With the mathe-
matical block in the stroma, the morphostat concentra-
tion in the stroma indirectly influenced the morphostat
concentration in the epithelial cells on the other side of
the blockage through a chain of cells around the blockage,
at which point the morphostat concentration was
Solid block in the stroma: multiple rounds Figure 3
Solid block in the stroma: multiple rounds. The Initial State represents stable tissue architecture when a solid block is 
first inserted into the stroma. A round is one cycle of cell movement and morphostat update through all the cells. At Round 5 
a mass of aberrant cells forms above top layer cells, which persists through later rounds.
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reduced. Due to the lower morphostat concentrations
when the morphostat gradient was blocked, aberrant cells
were generated (Figure 2). With a solid morphostat block,
a sizeable number of aberrant cells were created (Figure
3). With a perforated block, only a few aberrant cells were
created (Figure 4).
The results were not qualitatively dependent on (i)
whether cell renewal was evaluated from middle to out-
side or vice versa; (ii) the number of repeated evaluations
of cell renewal in the layer above the stem cells (although
with only a few repeats open space remained at the end of
a round); (iii) the sloughing probability; and (iv) whether
the morphostat gradient was evaluated from left to right
or right to left. Initial temporary perturbations in the mor-
phostat field disappeared although sometimes they
resulted in the creation of aberrant cells. The main obser-
vation from varying aspects of the simulation (which was
not obvious beforehand) was that the cell renewal process
had little impact on the development of aberrant cells,
which was primarily driven by the morphostat gradient.
Discussion
In the model of carcinogenesis described here, the aber-
rant cells remain in the tissue and may still exercise their
constitutive ability to proliferate leading to the histoarchi-
tectural disturbances present in cancers [1-3]. The lack of
a DNA mutation in the epithelial cells as a necessary ini-
tial event in carcinogenesis challenges the tenets of the
somatic mutation-theory of carcinogenesis [23]. How-
ever, our model does not preclude that mutations could
subsequently arise due to cytoarchitectural dislocations in
the aberrant cells. In support of this view, Prehn [24]
argued that cancer might cause mutations rather than vice
versa. Consistent with this line of thought, the aberrant
cells could become a founder population for cells that
may undergo genetic and epigenetic changes: mutations
may still play a role after the initiation of cancer by disrup-
tion of morphostats. Because, in our simulations, the per-
turbation of the morphostat gradient by the solid block
creates more aberrant cells than by the perforated block,
the chances for subsequent genetic and epigenetic changes
may be greater with the former.
Perforated block in the stroma: multiple rounds Figure 4
Perforated block in the stroma: multiple rounds. The Initial State represents stable tissue architecture when a solid 
block is first inserted into the stroma. A round is one cycle of cell movement and morphostat update through all the cells. At 
Round 5 scattered aberrant cells form above top layer cells, which persists through later rounds.
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Perhaps the strongest experimental evidence for the exist-
ence of aberrant cells created by low morphostat levels are
foreign-body implant experiments investigating preneo-
plastic cells (that could be either aberrant cells or cells
derived from aberrant cells). By transferring implants
from one rat to another, Brand et al. showed that preneo-
plastic cells first appear on the implant film and then in
the capsule surrounding the film [25]. Using radioactive
bone marrow, Barnes et al. showed that the preneoplastic
cells in foreign-body experiments could not have arisen in
the bone marrow [26], partly leading to the belief that the
preneoplastic cells could have originated from pericytes
around local capillaries [27]. More experimental work is
needed, perhaps involving the use of microarray assess-
ment of foreign-body experiments [7].
Our simulation provides evidence that disruption of mor-
phostats in the stroma could create aberrant epithelial
cells without the need to invoke an initiating mutation in
those epithelial cells. Rule 7, which states that low mor-
phostat levels induce aberrant cells, is certainly critical for
the model. However we did not know in advance whether
or not Rule 7 would lead to aberrant cells in the context of
cell renewal. Also, the results for the perforated versus the
solid block were not obvious.
Biological nature of morphostats
We did not need to specify the biological nature of a mor-
phostat, though we draw a parallel with established mor-
phogen gradients in embryogenesis. Potter predicted that
Wnt/wingless protein could be a morphostat [10] and
subsequently noted that there is considerable support for
this view [3,28-31].
Morphostat disruption and known carcinogens
It is important to emphasize that our model does not
require specifying the cause of the disruption of the mor-
phostat gradient. Possible causes could include physical
(radiation), biological (infectious agents), chemical car-
cinogens and/or foreign bodies inserted in the stroma.
Although radiation is known to cause DNA damage, vari-
ous studies suggest that radiation may initiate carcinogen-
esis via disruption of cell communication [8,31].
Radiation can induce genetic changes in neighboring cells
that receive no direct radiation (the "bystander effect")
but are affected through cell-to-cell communication [32].
Bone marrow cells irradiated with α-particles in vitro and
transplanted into mice induced chromosomal instability
up to one year after transplantation [33].
A major risk factor for hepatocellular carcinoma is chronic
infection by hepatitis B and C viruses. Although the cellu-
lar mechanisms of hepatocarcinogenesis are poorly
understood, recent work has pointed to dysregulation of
the WNT/Frizzled receptor elements (which, as men-
tioned previously, might be related to morphostats) as
one of the most common and earliest event in hepatocar-
cinogenesis [34].
Mouse salivary glands infected with polyoma virus (PV)
had different incidences of cancer depending on the stage
of development, suggesting that the neoplastic response
to PV is related to morphogenesis. Moreover when epithe-
lial and mesenchymal components were separated, trans-
planted, and then infected by PV, neither component
separately gave rise to tumors. Instead, tumors did arise
when the epithelial and mesenchymal components were
combined prior to transplantation and infection by PV
[35].
Some proven human carcinogens are not known to be
genotoxic. For example, tamoxifen, a selective estrogen
receptor modifier, affects growth factor action but is not
genotoxic [36]; similarly, the human carcinogen ethanol
has no known genotoxic capacity [37].
Critique of the evidence supporting the somatic-mutation 
theory
For a balanced presentation, it is important to discuss the
evidence in favor of the somatic-mutation theory. We
present seven arguments used to support the somatic
mutation theory and offer some alternative explanations
related to the theory that the initiating event is a disrup-
tion of the morphostat gradient which then may be fol-
lowed by genetic instability. The first four arguments rely
on a recent review article on oncogenes and cancer [38]
from which we quote extensively.
(1) "The first evidence that cancer arises from somatic
genetic alterations came from studies of Burkitt's lym-
phoma, in which one of three different translocations jux-
taposes an oncogene, MYC.... Since every malignant
lymphocyte carries the MYC translocation, deregulation
of the MYC oncogene is probably the initiating event
[38]." An alternative interpretation is that the MYC trans-
location indicates a late-stage event in carcinogenesis after
the disruption of the morphostat gradient.
(2) "Second, transfection experiments have shown that
mouse fibroblasts, when transfected in vitro with DNA
from human cancer cells, acquire some of the properties
of malignant cells (i.e. transformation). The transforming
activity of the DNA was traced to a human homologue of
the retroviral RAS oncogene [38]." An alternative explana-
tion is that the transforming activity in vitro would be
manifested in vivo as a disruption in morphostat gradi-
ents.
(3) "Third, the cloning and characterization of the chro-
mosomal breakpoints that are characteristic of follicular
lymphomas, and some diffuse large B-cell lymphomasBMC Cancer 2009, 9:89 http://www.biomedcentral.com/1471-2407/9/89
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have shown a juxtaposition of the BCL2 oncogene to
enhancer elements in the immunoglobulin heave-chain
locus, resulting in deregulation of BCL2 [38]." An alterna-
tive explanation is that these chromosomal breakpoints
occur after cancer initiation caused by disruption of mor-
phostats and their frequency increases due to selection
after the carcinogenesis process is underway.
(4) "Fourth, in transgenic mice that carry an activated
oncogene from a human tumor, cancers develop that
resemble the human tumor. That these cancers appear
only after a latent period suggests that alterations in other
genes must occur before progression to frank neoplasia
and occur – activation of a particular oncogene seems to
be necessary but not sufficient for the development of
cancer [38]." An alternative explanation is that a single or
multiple oncogene(s) disrupt(s) the morphostat gradient,
which is consistent with the latent period and the addi-
tional observation [39] in this study of transgenic mice
that tumors were not observed in every organ in which the
oncogene was aberrantly expressed.
(5) An additional argument in support of the somatic
mutation theory comes from animal experiments involv-
ing the formation of tumors after the insertion of onco-
genes into epithelial cells. In one instance, Bradbury et al.
[40] introduced the neu/erB-2 oncogene into mouse epi-
thelial cells by infecting cultures of mammary epithelium
with the retroviruses containing the oncogene, and then
injected 30 to 100 thousands cells into mammary fat pads
of mice from which the epithelium had been removed. If
no oncogene was inserted, normal epithelium developed,
but with the oncogene inserted a variety of abnormal epi-
thelial patterns arose. Remarkably, the tumor incidence
was rather low under this protocol (only one adenocarci-
noma in 43 injected mice), whereas a variety of infrequent
epithelial lesions were recorded in those mammary gland
transplants, including only four carcinomas in situ in 43
animal hosts. (See their Table 1). Equally noteworthy, the
prominent feature in the whole mounts reproduced in the
manuscript was the presence of abundant, apparently nor-
mal, ductal mammary tissue in the cleared fat pads
injected with neu/erB2 oncogene-carrying cells. Lack of
evidence that the neu/erB2 oncogene was present or
expressed in those normal ductal cells precludes deciding
whether the mutated oncogene was necessary, sufficient,
or merely irrelevant in these rare pre-carcinogenic events;
moreover, the neu antigen was not visualized in all of the
carcinomas in situ. We argue that these results are, in fact,
consistent with the oncogene causing a change in cells in
the epithelium that leads to a disruption of morphostats
and that the disruption of morphostats is the proximal
cause of cancer.
(6) A different type of evidence sometimes cited in sup-
port of the somatic mutation theory is the observation
that the incidence of some types of cancer increases rap-
idly with age. Such a rapid increase could be explained by
several genetic changes yet to be identified or by a few
genetic changes interspersed with clonal expansion. The
additional observation that various phenotypes must be
acquired suggests multiple mutations with no clonal
expansion or a mutator mutation (a mutation that gener-
ates more mutations) coupled with clonal expansion [41].
These observations could also be consistent with an initi-
ation of cancer due to disruption of the morphostat gradi-
ent followed by mutations and/or clonal expansion. The
increase in cancer incidence with age can also be
explained by aging of normal tissue (which might affect
the morphostat gradient). For instance, when tumors cells
were injected into the livers of rats, the tumor cells
regressed if the rats were young but progressed if the rats
were old [42].
(7) Hereditary cancers (which account for about 5% of all
clinical cancers) involve germ-line DNA mutations that
could be considered as supporting the somatic mutation
theory of carcinogenesis. An alternative explanation is
that DNA mutations in these hereditary cancers are
responsible for altered interactions among cells in a field
where morphogens might play an important role during
early development. The polyps in patients hemizygous for
a defective APC (disrupting the wnt/wingless pathway)
and the dysplasias preceding neoplasia both in retinoblas-
toma and in the lethal giant larva mutant in Drosophila
that eventually result in neuroblastomas are tissue organ-
ization alterations in which the underlying cause may be
altered morphogen/morphostat gradients [1].
Problems with a hybrid theory
Under the somatic mutation theory, the proximal cause of
cancer is one or more mutations in one or more cells
[43,44]. The theory expounded here is that the proximal
cause of cancer is a disruption of the morphostat gradient.
Some confusion between the theories may arise from the
fact that mutations have two different roles in the theory
that the proximal cause of cancer is a disruption of the
morphostat gradient. First, mutations are one possible
cause of a disruption in morphostats (but there are other
possible causes as well). Second, mutations are effects of
the initiation of cancer. This is not equivalent to a hybrid
theory.
Conclusion
We hypothesize that the proximal step in the initiation of
cancer is a disruption of a morphostat gradient. The argu-
ment that the oncogene experiments support only  the
somatic mutation theory does not account for the possi-
bility that the most crucial component of the causal path-
way could still require the disruption of morphostats.
Although a mutation or multiple successive mutations in
a single cell as the initial step cannot be ruled out, thereBMC Cancer 2009, 9:89 http://www.biomedcentral.com/1471-2407/9/89
Page 10 of 11
(page number not for citation purposes)
are many experiments, such as the aforementioned for-
eign-body induced cancers, that are inconsistent with a
mutation causing the initiation of cancer.
Our results challenge fundamental assumptions about
early carcinogenesis and highlight the need to incorporate
the study of stroma/epithelial interactions and morpho-
gens/morphostats [2,3,10,45-48]. We hope that the
results of this simulation will spur experimentalists to
seek to identify relevant morphostats and test some fun-
damental assumptions about early carcinogenesis. In
addition, the implications for the development of experi-
mental systems are profound, suggesting that two-dimen-
sional, and even three-dimensional, tissue-culture
experiments that focus solely on epithelial cells could be
missing a central mechanism of carcinogenesis.
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